Results 191 to 200 of about 252,763 (309)

Erratum to: Chemical analysis of bleach and hydroxide-based solutions after decontamination of the chemical warfare agent O-ethyl S-2-diisopropylaminoethyl methylphosphonothiolate (VX) [PDF]

, 2014
Farrha B. Hopkins, Matthew R. Gravett, Adam J. Self, M. Wang, H. C. Chua, H. S. Nancy Lee, James T. A. Jones, Christopher M. Timperley, James R. Riches   +8 more
openalex   +1 more source

L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators? [PDF]

Int J Mol Sci
Kondratyeva E, Efremova A, Melyanovskaya Y, Krasnova M, Milovanov M, Shchagina O, Stepanova A, Voronkova A, Sherman V, Kutsev S, Goldshtein D.   +10 more
europepmc   +1 more source

Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis. [PDF]

J Pers Med
Aalbers BL, Amatngalim GD, Aarts EM, Rodenburg LW, den Hertog-Oosterhoff LA, Heijerman HGM, Beekman JM.   +6 more
europepmc   +1 more source

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation [PDF]

, 2011
John P. Clancy, Steven M. Rowe, Frank J. Accurso, Moira L. Aitken, Raouf Amin, Melissa A. Ashlock, Manfred Ballmann, Michael Boyle, Inez Bronsveld, Preston W. Campbell, K. De Boeck, Scott H. Donaldson, Henry L. Dorkin, Jordan Dunitz, Peter R. Durie, Manu Jain, Anissa Leonard, Karen McCoy, Richard B. Moss, Joseph M. Pilewski, Daniel Rosenbluth, Ronald C. Rubenstein, Michael S. Schechter, Martyn C. Botfield, Claudia L. Ordoñez, G Spencer-Green, Laurent Vernillet, Steve Wisseh, Karl Yen, Michael W. Konstan   +29 more
openalex   +1 more source

Structure-based identification of Jervine as a potent dual-targeting inhibitor of cell cycle kinases. [PDF]

Front Pharmacol
Sulaimani MN, Imtiyaz K, Hassan MI, Husain FM, Rathi A, Farooq MO, Ashraf A, Dohare R, Sohal SS, Noor S.   +9 more
europepmc   +1 more source

New Role of Protein Misfolding Corrector in the ER Stress-Inflammation Axis: Possible Therapeutic Indication in Neuronal and Epithelial Tumor Cells. [PDF]

Int J Mol Sci
Pecoraro M, Serra A, Lamberti MJ, Pascale M, Franceschelli S.   +4 more
europepmc   +1 more source

Measurement of the B⁰_s lifetime using the semileptonic decay channel B⁰_s → D^-_sμ⁺vX

, 2009
Marco Antonio Carrasco Lizarraga
openalex   +2 more sources

Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit [PDF]

, 2014
Randal A. Byrn, Steven J.M. Jones, Hamilton B. Bennett, Chris Bral, Michael P. Clark, Marc Jacobs, Ann D. Kwong, Mark W. Ledeboer, Joshua R. Leeman, Colleen F. McNeil, Mark A. Murcko, Azin Nezami, Emanuele Perola, René Rijnbrand, Kumkum Saxena, Alice Tsai, Yi Zhou, Paul S. Charifson   +17 more
openalex   +1 more source

Beyond CFTR: Ivacaftor's role in restoring cellular redox balance and preventing ferroptosis. [PDF]

Redox Biol
Rubin M, Artusi I, Rossetto M, Gucciardi A, Di Paolo ML, Bosello Travain V, Zeppilli D, Orian L, Miotto G, Friedmann Angeli JP, Cozza G.   +10 more
europepmc   +1 more source

Data from ATR Inhibitor M6620 (VX-970) Enhances the Effect of Radiation in Non–Small Cell Lung Cancer Brain Metastasis Patient-Derived Xenografts

, 2023
Florian Wiesinger, Jacob H. Elnaggar, Haley J. VanBeek, Ashley C. Kromke, Justin H. Skiba, Saakshi Kaushik, Lindsey Abel, Paul A. Clark, Colin A. Longhurst, Kwangok P. Nickel, Ticiana Leal, Shuang G. Zhao, Randall J. Kimple   +12 more
openalex   +1 more source